Lars Lannfelt | BiotechTV

top of page

Lars Lannfelt, inventor of the approved (in the U.S. and elsewhere) Alzheimer's medicine Leqembi, describes how the drug works and shares his understanding of Alzheimer's disease

Professor Lannfelt recounts the history of researching amyloid beta and explains why he thinks it is vital to target amyloid beta...

Bright Minds

Sep 21, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page

Lars Lannfelt, inventor of the approved (in the U.S. and elsewhere) Alzheimer's medicine Leqembi, describes how the drug works and shares his understanding of Alzheimer's disease

Follow BiotechTV

Sponsors

Sponsor Spotlight